We are live on !
Find out more
Omni Partners US Portfolio holdings
AUM
$1.95B
Turnover
45.39%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$319M
(-14%)
Cap. Flow
-$362M
Cap. Flow % of AUM
Cap. Flow %
-18.57%
Top 10 Holdings %
Top 10 Hldgs %
50.07%
Holding
304
New
78
Increased
103
Reduced
62
Closed
60
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$127M |
| 2 |
CLDR
Cloudera, Inc.
CLDR
|
+$103M |
| 3 |
CVA
Covanta Holding Corporation
CVA
|
+$55.8M |
| 4 |
WBT
Welbilt, Inc.
WBT
|
+$54.6M |
| 5 |
IHS Markit Ltd. Common Shares
INFO
|
+$49.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$234M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$111M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$90M |
| 5 |
NAV
Navistar International
NAV
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.59% |
| 2 | Financials | 20.93% |
| 3 | Healthcare | 13.9% |
| 4 | Industrials | 13.46% |
| 5 | Communication Services | 11.51% |
Similar funds
Omni Partners US's Q3 2021 Portfolio in Review
As of Q3 2021, Omni Partners US held 304 positions worth $1.95B, down 14% from $2.27B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Omni Partners US withdrew a net $362M in Q3 2021, closing 60 positions and reducing 62 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $326M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 40% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Omni Partners US opened a new position in Covanta Holding Corporation worth $56.8M.
- Omni Partners US's largest Q3 2021 buy was Covanta Holding Corporation: 2,822,693 shares worth $56.8M.
- Omni Partners US added most to Kansas City Southern in Q3 2021, an estimated $127M increase.
- Omni Partners US's biggest Q3 2021 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $37.2M.
- Omni Partners US fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $326M.
- Omni Partners US's ten largest holdings make up 50% of its $1.95B portfolio in Q3 2021.
- Omni Partners US opened 78 new positions and closed 60 in Q3 2021.
- Omni Partners US's portfolio value fell 14% quarter-over-quarter to $1.95B.
Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.